Bacampicillin Pregnancy and Breastfeeding Warnings
Brand names: Spectrobid
Bacampicillin Pregnancy Warnings
Bacampicillin has been assigned to pregnancy category B by the FDA. Animal studies failed to reveal evidence of fetal harm. There are no controlled data in human pregnancy. Bacampicillin should only be given during pregnancy when need has been clearly established.
Bacampicillin Breastfeeding Warnings
Bacampicillin is converted in vitro to ampicillin. Ampicillin is excreted into human milk in small amounts. Candidiasis and diarrhea have been reported in an infant exposed to ampicillin via breast milk; however, the cause was uncertain. The American Academy of Pediatrics considers some other penicillins (amoxicillin, ticarcillin) compatible with breast-feeding. The manufacturer recommends caution when administering ampicillin-class antibiotics to nursing women.
See also
References for pregnancy information
- (2002) "Product Information. Spectrobid (bacampicillin)." Roerig Division
References for breastfeeding information
- Campbell AC, McElnay JC, Passmore CM (1991) "The excretion of ampicillin in breast milk and its effect on the suckling infant." Br J Clin Pharmacol, 31, p230
- Matheson I, Samseth M, Sande HA (1988) "Ampicillin in breast milk during puerperal infections." Eur J Clin Pharmacol, 34, p. 657-9
- (2002) "Product Information. Spectrobid (bacampicillin)." Roerig Division
- American Academy of Pediatrics Committee on Drugs (2001) "The transfer of drugs and other chemicals into human milk" Pediatrics, 108, p. 776-789
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.